145 related articles for article (PubMed ID: 16883086)
1. Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease.
Mashayekhi F; Salehin Z
Ann Saudi Med; 2006; 26(4):278-82. PubMed ID: 16883086
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.
Counts SE; He B; Prout JG; Michalski B; Farotti L; Fahnestock M; Mufson EJ
Curr Alzheimer Res; 2016; 13(7):800-8. PubMed ID: 26825093
[TBL] [Abstract][Full Text] [Related]
3. Increased CSF levels of nerve growth factor in patients with Alzheimer's disease.
Hock C; Heese K; Müller-Spahn F; Huber P; Riesen W; Nitsch RM; Otten U
Neurology; 2000 May; 54(10):2009-11. PubMed ID: 10822447
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
Marksteiner J; Pirchl M; Ullrich C; Oberbauer H; Blasko I; Lederer W; Hinterhuber H; Humpel C
Pharmacology; 2008; 82(3):214-20. PubMed ID: 18810245
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
Pentz R; Iulita MF; Ducatenzeiler A; Videla L; Benejam B; Carmona‐Iragui M; Blesa R; Lleó A; Fortea J; Cuello AC
Alzheimers Dement; 2021 Apr; 17(4):605-617. PubMed ID: 33226181
[TBL] [Abstract][Full Text] [Related]
6. Expression of nerve growth factor in cerebrospinal fluid of congenital hydrocephalic and normal children.
Mashayekhi F; Salehi Z
Eur J Neurol; 2005 Aug; 12(8):632-7. PubMed ID: 16053473
[TBL] [Abstract][Full Text] [Related]
7. Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease.
Salehi Z; Mashayekhi F; Naji M
Biofactors; 2008; 33(2):99-106. PubMed ID: 19346585
[TBL] [Abstract][Full Text] [Related]
8. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
9. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
[TBL] [Abstract][Full Text] [Related]
10. [Endogenous nerve growth factor in patients with Alzheimer s disease].
Serrano-Sánchez T; Robinson-Agramonte MA; Lorigados-Pedre L; Díaz-Armesto I; González-Fraguela ME; Dorta-Contreras AJ
Rev Neurol; 2001 May 1-15; 32(9):825-8. PubMed ID: 11424032
[TBL] [Abstract][Full Text] [Related]
11. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease.
Mashayekhi F; Hadavi M; Vaziri HR; Naji M
J Clin Neurosci; 2010 Mar; 17(3):357-9. PubMed ID: 20079650
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM; Volicer L; Hauser SL; Wands JR
Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
[TBL] [Abstract][Full Text] [Related]
14. A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease.
Öhrfelt A; Brinkmalm A; Dumurgier J; Zetterberg H; Bouaziz-Amar E; Hugon J; Paquet C; Blennow K
Neuroscience; 2019 Nov; 420():136-144. PubMed ID: 30528858
[TBL] [Abstract][Full Text] [Related]
15. Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
Khoonsari PE; Shevchenko G; Herman S; Remnestål J; Giedraitis V; Brundin R; Degerman Gunnarsson M; Kilander L; Zetterberg H; Nilsson P; Lannfelt L; Ingelsson M; Kultima K
J Alzheimers Dis; 2019; 67(2):639-651. PubMed ID: 30614806
[TBL] [Abstract][Full Text] [Related]
16. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.
Blennow K; Davidsson P; Wallin A; Gottfries CG; Svennerholm L
Int Psychogeriatr; 1994; 6(1):13-22; discussion 59-60. PubMed ID: 8054491
[TBL] [Abstract][Full Text] [Related]
18. Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.
Chatterjee M; Del Campo M; Morrema THJ; de Waal M; van der Flier WM; Hoozemans JJM; Teunissen CE
Alzheimers Res Ther; 2018 Jun; 10(1):52. PubMed ID: 29859129
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro.
Eriksdotter M; Navarro-Oviedo M; Mitra S; Wahlberg L; Linderoth B; Tjernberg LO; Behbahani H
Exp Cell Res; 2018 Oct; 371(1):175-184. PubMed ID: 30092220
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Fiorini M; Bongianni M; Benedetti MD; Monaco S; Zanusso G
J Alzheimers Dis; 2018; 66(1):219-227. PubMed ID: 30282368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
